Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CHLORDIAZEPOXIDE HYDROCHLORIDE USP, with a corresponding US DMF Number 35606.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 04, 2021, and payment made on September 20, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II